SCHEMBL6948619

SCHEMBL6948619

Nc1nc(Cc2ccsc2)c2nc[nH]c2n1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PNP P00491 5/20 0.41
MPO P05164 1/20 0.36
TAAR1 Q96RJ0 1/20 0.33
TLR7 Q9NYK1 1/20 0.32
GHSR Q92847 1/20 0.32
PIM1 P11309 2/20 0.32
DYRK1A Q13627 2/20 0.32
DYRK2 Q92630 2/20 0.32
DYRK1B Q9Y463 2/20 0.32
CLK1 P49759 1/20 0.32
CDK9 P50750 1/20 0.32
ADORA3 P0DMS8 2/20 0.32
ADORA2A P29274 2/20 0.32
ADORA2B P29275 2/20 0.32
ADORA1 P30542 2/20 0.32
CDK1 P06493 1/20 0.31
PABPC1 P11940 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6946585 0.80 MPO (0.40) PNPMPOADORA2ACDK1
SCHEMBL6945083 0.79 PIN1 (0.44) MPOTLR7
SCHEMBL6944455 0.76 HRH4 (0.44) PNPMPO
SCHEMBL6941905 0.76 ALDH1A1 (0.50) MPOTLR7
SCHEMBL6947940 0.75 PIN1 (0.48) MPOTLR7ADORA2AADORA1
SCHEMBL6939911 0.75 DHFR (0.47) MPOTAAR1ADORA3ADORA2AADORA1
SCHEMBL6950768 0.74 CYP17A1 (0.39) MPOADORA3ADORA2AADORA2BADORA1
Ammonia Solution, Strong SCHEMBL17009431 0.73 KDM4A (0.41) PNPMPOADORA3ADORA2AADORA2B
SCHEMBL12844134 0.72 HEXA (0.37) CDK1
SCHEMBL6944400 0.72 HRH3 (0.42) PNPMPOTAAR1ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1349857-A1 PURINE DERIVATIVES AS PURINERGIC RECEPTOR ANTAGONISTS VERNALIS RESEARCH LIMITED (GB) 2003-10-08 EP disclosed
WO-2002055521-A1 PURINE DERIVATIVES AS PURINERGIC RECEPTOR ANTAGONISTS VERNALIS RESEARCH LIMITED (GB) 2002-07-18 WO disclosed